Bruker (BRKR) Restructuring Costs (2010 - 2025)

Bruker (BRKR) posted Restructuring Costs of -$3.6 million for Q4 2025, down 187.8% on a QoQ basis from $4.1 million in Q3 2025, and down 117.73% year-over-year from $20.3 million in Q4 2024.

Bruker (BRKR) Restructuring Costs (2010 - 2025) Analysis & Trends

Bruker's Restructuring Costs history runs 13 years deep, the most recent figure standing at -$3.6 million for Q4 2025.

  • Quarterly Restructuring Costs fell 117.73% year-over-year to -$3.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26.9 million (up 3.46% YoY) and the FY2025 annual result came in at $6.4 million, down 79.22% from the prior year.
  • Restructuring Costs was -$3.6 million for Q4 2025 at Bruker, down from $4.1 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $20.3 million in Q4 2024 and bottomed at -$3.6 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Bruker 9.46 Bn 9.50 Bn 379.80 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.60 Mn
Sep 30, 2025 4.10 Mn
Dec 31, 2024 20.30 Mn
Sep 30, 2024 6.10 Mn
Sep 30, 2020 900,000.00
Dec 31, 2019 -1.30 Mn
Sep 30, 2019 900,000.00
Jun 30, 2019 1.20 Mn
Mar 31, 2019 3.80 Mn
Dec 31, 2018 1.10 Mn
Sep 30, 2018 1.20 Mn
Jun 30, 2018 100,000.00
Mar 31, 2018 1.00 Mn
Dec 31, 2017 700,000.00
Sep 30, 2017 500,000.00
Jun 30, 2017 2.90 Mn
Mar 31, 2017 400,000.00
Dec 31, 2016 900,000.00
Sep 30, 2016 200,000.00
Jun 30, 2016 7.90 Mn